City Of Rockford v. Mallinckrodt ARD, Inc., et al
Case Number:
3:17-cv-50107
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Arnold & Porter
- Bartimus Frickleton
- Bryan Cave
- Cleary Gottlieb
- Cooley LLP
- Haviland Hughes
- Latham & Watkins
- Meyers & Flowers
- Milberg Coleman
- Quinn Emanuel
- Reno & Zahm
- Skadden Arps
- Wisner Baum
Companies
Sectors & Industries:
-
April 01, 2024
'Unreliable' Theory Dooms City's Acthar Antitrust Cert. Bid
The city of Rockford has presented "unreliable" damages evidence that cannot warrant giving class treatment to its claim that pharmacy benefits manager Express Scripts engaged in a scheme to fix prices for the seizure medication Acthar, an Illinois federal judge has said.
-
January 18, 2024
Quinn Emanuel Says Judge Is Right To Block Subpoena
A month after a federal judge allowed Quinn Emanuel to escape a subpoena to produce communications the firm said were protected amid a drug pricing antitrust case brought by the city of Rockford, Illinois, the firm is still defending its right to withhold the documents, saying Rockford's objections to the ruling "lack merit."
-
December 12, 2023
Quinn Emanuel Escapes Drug Pricing Antitrust Subpoena
The city of Rockford, Illinois, will not have access to communications held by Quinn Emanuel Urquhart & Sullivan LLP concerning an exclusive drug distribution agreement, an Illinois federal judge determined, quashing the city's attempt to view the documents amid its antitrust suit against a pharmaceutical distributor.
-
September 11, 2023
Latham, Quinn Emanuel Pressed For Docs In Antitrust Case
The city of Rockford, Illinois, is pushing two law firms that represent pharmacy benefits manager Express Scripts and drug manufacturer Mallinckrodt PLC in antitrust litigation and a related bankruptcy proceeding to comply with subpoenas the city issued over disputed contractual documents that concern alleged price-fixing of a seizure medication.
-
July 11, 2023
Express Scripts Fights Acthar Antitrust Class Cert. Bid
Express Scripts urged an Illinois federal court to reject a bid by the city of Rockford to certify a pair of classes over an alleged scheme to fix prices for the seizure medication Acthar, arguing that too many of the supposed class members were never harmed by the alleged conspiracy.
-
May 30, 2023
Acthar Buyers Still Want Class Treatment In Antitrust Suit
The city of Rockford, Illinois, has renewed its bid for class certification of federal antitrust claims targeting an alleged scheme to fix prices of Mallinckrodt's seizure medication Acthar at more than $23,000, arguing it will use common evidence to prove thousands of purchasers' claims.
-
January 12, 2023
'I've Had My Fill,' Ill. Judge Says In Express Scripts Suit
An Illinois federal judge tore into the city of Rockford and pharmacy benefits manager Express Scripts on Thursday over their apparent inability to work together in an antitrust suit over an anti-seizure drug, calling their recent conduct "nonsense" that he refuses to participate in.
-
January 04, 2023
Express Scripts Antitrust Suit Is 'Off The Rails,' Judge Says
An Illinois federal judge overseeing antirust claims over Mallinckrodt's Acthar seizure medication demanded an explanation for why the nearly five-year-old case "appears to have gone off the rails," the latest controversy in a case defined by tense discovery disputes and sanctions bids.
-
December 19, 2022
Express Scripts Says Sanction Bid A Tactic Of A Failed Case
Express Scripts lashed out at a sanctions bid from the city of Rockford, Illinois, that accuses the company of failing to preserve evidence in an antitrust case, suggesting that the town's allegations are just a common tactic of an attorney who "litter[s] his cases with 'sanctions' requests."
-
November 17, 2022
Ill. City Says Express Scripts Spoiled Docs In Acthar Case
The city of Rockford, Illinois, on Wednesday urged a federal judge to sanction Express Scripts for failing to preserve evidence in a case accusing it of scheming with Mallinckrodt to dramatically inflate the price of the seizure medication Acthar, claiming that the pharmacy got rid of key emails from its leadership discussing the scheme.